A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients

BACKGROUND: Biochemical recurrence (BCR) is considered a decisive risk factor for clinical recurrence and the metastasis of prostate cancer (PCa). Therefore, we developed and validated a signature which could be used to accurately predict BCR risk and aid in the selection of PCa treatments. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiangkun, Lv, Daojun, Eftekhar, Md, Khan, Aisha, Cai, Chao, Zhao, Zhijian, Gu, Di, Liu, Yongda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807327/
https://www.ncbi.nlm.nih.gov/pubmed/33457230
http://dx.doi.org/10.21037/tau-20-1019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807327/
https://www.ncbi.nlm.nih.gov/pubmed/33457230
http://dx.doi.org/10.21037/tau-20-1019

Ejemplares similares